Trial Profile
Safety of a Single Dose (Participants Aged 9 Years and Older) or Two Doses Given 28 Days Apart (Participants Aged 6 Months to 8 Years) of the Shenzhen Quadrivalent Influenza Vaccine (Split Virion), Inactivated
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccines (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi Pasteur
- 07 Aug 2019 Status changed from active, no longer recruiting to completed.
- 23 May 2019 Status changed from recruiting to active, no longer recruiting.
- 08 Apr 2019 Status changed from not yet recruiting to recruiting.